Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Incidence and Clinical Impact of TET2 Mutations in Acute Myeloid Leukemia Patients Treated within the EORTC/GIMEMA AML-12/06991 AML Trial.

Blood (2009) 114 (22): 2609.

https://doi.org/10.1182/blood.V114.22.2609.2609

Published: 2009

Journal Articles

Allogeneic (Allo-) or Autologous (Auto-) Peripheral Blood Stem Cell Transplantation (SCT) Randomized Versus a Second Intensive Consolidation after a Common Induction and Consolidation Course in Patients with Bad Prognosis Myelodysplastic Syndromes and Acute Myelogenous Leukemia Following MDS of More Than 6 Months Duration: The Final Analysis of a Joint Study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups.

Blood (2005) 106 (11): 794.

https://doi.org/10.1182/blood.V106.11.794.794

Published: 2005

Journal Articles

Prognostic Impact of Genetic Characterization in the GIMEMA LAM99P Study for Newly Diagnosed Adult AML. Relevance of Combined Analysis of Conventional Karyotyping, FLT3 and NPM Mutational Status.

Blood (2005) 106 (11): 226.

https://doi.org/10.1182/blood.V106.11.226.226

Published: 2005

Journal Articles

A New Prognostic Disease Specific Model To Predict Survival after Intensive Antileukemic Treatment for Young Patients with Poor-Risk MDS and AML: Results of the CRIANT and AML-10 Studies Conducted by the EORTC/GIMEMA/SAKK/HOVON/EBMT Groups.

M. Oosterveld, MD, S. Suciu, M.Sc, P. Muus, MD, M. Delforge, MD, A. Belhabri, MD, C. Aul, MD, D. Selleslag, MD, A. Ferrant, MD, J.-P. Marie, MD, S. Amadori, MD, U. Jehn, MD, U. Hess, MD, R. Willemze, MD, E. Hellstrom-Lindberg, MD, M. Vignetti, MD, B. Labar, MD, F. Mandelli, MD, T. De Witte, MD

Blood (2004) 104 (11): 2020.

https://doi.org/10.1182/blood.V104.11.2020.2020

Published: 2004

Journal Articles

Valproic Acid Plus Retinoic Acid Induce Myeloid Differentiation in Chemotherapy-Resistant Acute Myeloid Leukemia Patients.

C. Nervi, MD, F. Lo Coco, MD, S. Minucci, MD, A. Careddu tech., R. Fiorini, MD, E. Finolezzi, MD, N. Noguera, PHD, L. Travaglini, PHD, V. Gelmetti, PHD, D. Diverio, PHD, S. Fenu, MD, M. Mancini, MD, C. Tatarelli, MD, M.A. Aloe Spiriti, MD, M.C. Petti, MD, G. Cimino, MD, F. Mandelli, MD, S. Amadori, MD, P.G. Pelicci, MD

Blood (2004) 104 (11): 1805.

https://doi.org/10.1182/blood.V104.11.1805.1805

Published: 2004

Journal Articles

Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia

G Del Poeta, R Stasi, G Aronica, A Venditti, MC Cox, A Bruno, F Buccisano, M Masi, M Tribalto, S Amadori, G Papa

Blood (1996) 87 (5): 1997–2004.

https://doi.org/10.1182/blood.V87.5.1997.1997

Published: 1996

Journal Articles

Selective expression of fos proto-oncogene in human acute myelomonocytic and monocytic leukemias: a molecular marker of terminal differentiation

F Mavilio, U Testa, NM Sposi, M Petrini, E Pelosi, C Bordignon, S Amadori, F Mandelli, C Peschle

Blood (1987) 69 (1): 160–164.

https://doi.org/10.1182/blood.V69.1.160.160

Published: 1987

Journal Articles

Bromodeoxyuridine treatment of normal adult erythroid colonies: an in vitro model for reactivation of human fetal globin genes

P Comi, S Ottolenghi, B Giglioni, G Migliaccio, AR Migliaccio, E Bassano, S Amadori, G Mastroberardino, C Peschle

Blood (1986) 68 (5): 1036–1041.

https://doi.org/10.1182/blood.V68.5.1036.1036

Published: 1986

Journal Articles

Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia

GV Dahl, DK Kalwinsky, S Murphy, AT Look, S Amadori, M Kumar, R Novak, SL George, C Mason, AM Mauer, JV Simone

Blood (1982) 60 (4): 856–863.

https://doi.org/10.1182/blood.V60.4.856.856

Published: 1982

Journal Articles

Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients

M Baccarani, G Corbelli, S Amadori, A Drenthe-Schonk, R Willemze, G Meloni, PL Cardozo, C Haanen, F Mandelli, S Tura

Blood (1982) 60 (3): 677–684.

https://doi.org/10.1182/blood.V60.3.677.677

Published: 1982

NARROW

Incidence and Clinical Impact of TET2 Mutations in Acute Myeloid Leukemia Patients Treated within the EORTC/GIMEMA AML-12/06991 AML Trial.

Prognostic Impact of Genetic Characterization in the GIMEMA LAM99P Study for Newly Diagnosed Adult AML. Relevance of Combined Analysis of Conventional Karyotyping, FLT3 and NPM Mutational Status.

A New Prognostic Disease Specific Model To Predict Survival after Intensive Antileukemic Treatment for Young Patients with Poor-Risk MDS and AML: Results of the CRIANT and AML-10 Studies Conducted by the EORTC/GIMEMA/SAKK/HOVON/EBMT Groups.

Valproic Acid Plus Retinoic Acid Induce Myeloid Differentiation in Chemotherapy-Resistant Acute Myeloid Leukemia Patients.

Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia

Selective expression of fos proto-oncogene in human acute myelomonocytic and monocytic leukemias: a molecular marker of terminal differentiation

Bromodeoxyuridine treatment of normal adult erythroid colonies: an in vitro model for reactivation of human fetal globin genes

Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia

Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only